Sukul, Devraj <br/><br/>
The comparative safety and effectiveness of bivalirudin versus heparin monotherapy in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan cardiovascular consortium.  [electronic resource] 

 -  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions  Nov 2017 
 - 724-732 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Observational Study 
<br/><br/><label>ISSN: </label>1522-726X 
<br/><br/><label>Standard No.: </label>10.1002/ccd.27001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anticoagulants--adverse effects<br/>Antithrombins--adverse effects<br/>Blue Cross Blue Shield Insurance Plans<br/>Comparative Effectiveness Research<br/>Coronary Artery Disease--complications<br/>Female<br/>Hemorrhage--chemically induced<br/>Heparin--adverse effects<br/>Hirudins--adverse effects<br/>Humans<br/>Logistic Models<br/>Male<br/>Michigan<br/>Middle Aged<br/>Odds Ratio<br/>Peptide Fragments--adverse effects<br/>Percutaneous Coronary Intervention--adverse effects<br/>Propensity Score<br/>Recombinant Proteins--adverse effects<br/>Registries<br/>Renal Dialysis--adverse effects<br/>Renal Insufficiency, Chronic--complications<br/>Retrospective Studies<br/>Risk Factors<br/>Stents<br/>Thrombosis--diagnosis<br/>Time Factors<br/>Treatment Outcome